How can I regulate my menstrual flow if it has decreased?

Menstrual flow reduction—often referred to clinically as hypomenorrhea—is defined as a menstrual period with abnormally light bleeding, typically lasting fewer than two days or involving total blood loss of less than 20 mL per cycle. While occasional light periods may be benign and related to lifestyle factors (e.g., recent weight loss, increased exercise, or mild stress), persistent or newly developed hypomenorrhea warrants medical evaluation to identify underlying causes.

Common etiologies include hormonal imbalances—particularly hypothalamic-pituitary-ovarian axis dysfunction, such as functional hypothalamic amenorrhea or early ovarian insufficiency; structural uterine issues like intrauterine adhesions (Asherman syndrome) following dilation and curettage or infection; chronic endometritis; or iatrogenic causes including prolonged use of combined hormonal contraceptives or progestin-only methods. Thyroid disorders (both hypo- and hyperthyroidism), elevated prolactin levels (hyperprolactinemia), and metabolic conditions such as uncontrolled diabetes or celiac disease may also contribute.

Initial assessment should include a detailed menstrual history (onset, duration, volume, associated symptoms), reproductive history, medication review, and physical examination—including pelvic exam when appropriate. Laboratory testing often includes serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, thyroid-stimulating hormone (TSH), prolactin, and possibly anti-Müllerian hormone (AMH) to assess ovarian reserve. Pelvic ultrasound is recommended to evaluate endometrial thickness, uterine anatomy, and ovarian morphology. In cases of suspected intrauterine pathology—especially with prior uterine surgery or recurrent pregnancy loss—saline infusion sonohysterography or diagnostic hysteroscopy may be indicated.

Management is tailored to the underlying diagnosis. For hypothalamic amenorrhea, restoring energy balance through nutritional counseling, stress reduction, and gradual modification of exercise intensity is foundational. Hormonal therapy—such as cyclic estrogen-progestin regimens—may be used temporarily to support endometrial health and regulate cycles, particularly if fertility is desired or bone health is a concern. In Asherman syndrome, hysteroscopic adhesiolysis followed by postoperative estrogen therapy and mechanical barrier placement (e.g., intrauterine balloon) improves outcomes. Thyroid or prolactin abnormalities require targeted pharmacologic treatment. Importantly, self-treatment with herbal remedies or unregulated supplements is not evidence-based and may delay appropriate diagnosis and intervention.

Patients experiencing new-onset or progressive menstrual lightening—especially when accompanied by infertility, hot flashes, vaginal dryness, or other systemic symptoms—should seek timely gynecologic or reproductive endocrinology consultation. Early evaluation helps preserve fertility potential, prevent long-term complications such as osteoporosis, and address quality-of-life concerns effectively.